Lund Melanoma Study Group
1 – 10 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study
- 2017
- Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
- Association analysis identifies 65 new breast cancer risk loci
- Melanoma genetics and genomics
- Högt ER-beta-uttryck starkt skyddande mot återfall hos de kvinnor som fått cytostatika
- Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
- Cancer risks and survival in patients with multiple primary melanomas : Association with family history of melanoma and germline CDKN2A mutation status
- Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men
- Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling
- NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics